142280.Kq
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
Business. The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
The company maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.39, indicating a moderate reliance on debt financing. Its liquidity position is characterized as medium, with a current ratio of 1.15, suggesting it has sufficient short-term assets to cover its short-term liabilities, but with limited excess. The company reported a net cash position that is negative after subtracting total debt, which may signal potential liquidity constraints in the near term.
In terms of profitability, the company's return on equity (ROE) of 8.26% and return on assets (ROA) of 4.05% are key indicators of its efficiency in generating returns for shareholders and asset utilization, respectively. These figures should be compared against the industry median to determine whether the company is outperforming or underperforming its peers. The operating margin, derived from the operating income of 2,739,507,600 KRW on revenue of 108,413,453,300 KRW, suggests a healthy margin, but the exact industry median is required for a more precise assessment.
The company's revenue is not segmented by geographic regions or product lines in the provided data, making it difficult to assess the geographic or segment concentration of its revenue. However, the absence of detailed segment data implies that the company may not have a highly diversified revenue base, which could expose it to regional or product-specific risks.
The company's growth trajectory is not explicitly outlined in the provided data, but the financial snapshot does not indicate a significant change in revenue or operating income from the previous period. The outlook for the current and next fiscal years is not provided, so it is not possible to determine the expected direction of growth or the magnitude of the change.
The risk assessment indicates a low potential for dilution, which is a positive sign for shareholders. However, the company's liquidity risk is rated as medium, which could be a concern if short-term obligations increase or if cash flow from operations is disrupted. The risk assessment does not provide a detailed breakdown of the sources of dilution, but the low rating suggests that the company is not currently issuing a large number of new shares or using other dilutive financing methods.
There are no recent events, such as filings or transcripts, provided in the data to inform the company's current situation or strategic direction. The absence of such information means that the company's recent performance and strategic initiatives cannot be assessed in detail.
- The company has a moderate debt-to-equity ratio, indicating a balanced capital structure.
- The company's ROE and ROA are key indicators of its profitability and asset efficiency.
- The company's liquidity position is medium, with a current ratio of 1.15.
- The company's risk of dilution is low, which is favorable for shareholders.
- The company's growth trajectory and strategic direction are not clearly outlined in the provided data.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 142280.KQ Market data — financials · 2026-05-26